Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference24 articles.
1. Rosenbrock H, Desch M, Kleiner O, Dorner-Ciossek C, Schmid B, Keller S, et al. Evaluation of pharmacokinetics and pharmacodynamics of BI 425809, a novel GlyT1 inhibitor: translational studies. Clin Transl Sci. 2018;11:616–23.
2. Burkard U, Desch M, Shatillo Y, Wunderlich G, Mack SR, Schlecker C, et al. The absolute bioavailability, absorption, distribution, metabolism, and excretion of BI 425809 Administered as an oral dose or an oral dose with an intravenous microtracer dose of [14C]-BI 425809 in healthy males. Clin Drug Invest. 2022;42:87–99.
3. Hamilton RA, Garnett WR, Kline BJ. Determination of mean valproic acid serum level by assay of a single pooled sample. Clin Pharmacol Amp Ther. 1981;29:408–13.
4. Mannens G, Huang ML, Meuldermans W, Hendrickx J, Woestenborghs R, Heykants J. Absorption, metabolism, and excretion of risperidone in humans. Drug Metab Dispos Biol Fate Chem. 1993;21:1134–41.
5. Stiff DD, Robicheau JT, Zemaitis MA. Reductive metabolism of the anticonvulsant agent zonisamide, a 1,2-benzisoxazole derivative. Xenobiotica. 1992;22:1–11.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献